Nicotinic Acid (Niacin) Receptor Agonists: Will They Be Useful Therapeutic Agents?
Open Access
- 3 December 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (11) , S53-S61
- https://doi.org/10.1016/j.amjcard.2007.09.080
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Effect of niacin on lipoproteins and atherosclerosisFuture Lipidology, 2006
- Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary reviewJournal of Internal Medicine, 2005
- Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus PanelCurrent Medical Research and Opinion, 2005
- Effect of Lipid-Lowering Drug Therapy on Small-Dense Low-Density LipoproteinAnnals of Pharmacotherapy, 2005
- Niacin therapy in atherosclerosisCurrent Opinion in Lipidology, 2004
- Effects of extended-release niacin on lipoprotein subclass distributionThe American Journal of Cardiology, 2003
- Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemiaThe American Journal of Cardiology, 2001
- Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease RegressionCirculation, 1999
- Effects of nicotinic acid on serum cholesterol concentrations of high density lipoprotein subfractions HDL2, and HDL3, in hyperlipoproteinaemiaJournal of Internal Medicine, 1990
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955